Juvoly B.V.

Located in the Netherlands, Juvoly B. V. specializes in AI-driven speech recognition and documentation solutions tailored for the healthcare sector, enhancing efficiency and streamlining patient consultation processes. Juvoly B.

V. provides advanced AI speech recognition and documentation solutions for the healthcare sector. Founded in 2023, the company is headquartered in Leiden, Netherlands. The founder's details are not disclosed, and there are no known pivots in its business strategy.

The company has completed a single deal as of January 26, 2026, when Tandem Health AB agreed to acquire Juvoly B. V. Financial terms were not disclosed, and it was not specified if Juvoly is a subsidiary or if it has any. Juvoly specializes in AI-driven speech recognition and documentation solutions tailored for the healthcare sector.

The company's primary offerings, including QuickConsult and PhoneAssist, streamline the documentation process during patient consultations, allowing healthcare professionals to focus on patient care rather than administrative tasks. QuickConsult facilitates both in-person and virtual consultations and integrates with various Electronic Patient Records (EPR) systems, while PhoneAssist is designed for efficient documentation of telephone consultations. These products serve a diverse client base, including over one-third of Dutch general practitioners and a wide range of healthcare professionals across the Netherlands. Juvoly's solutions are built to address common challenges in healthcare documentation, including language barriers and the need for quick access to medical resources, operating primarily within the Dutch market but also extending through its multilingual capabilities to support healthcare providers serving diverse populations.

Juvoly generates revenue through a subscription-based model for its flagship products, QuickConsult and PhoneAssist. Clients, primarily healthcare organizations and professionals, subscribe to these services to benefit from automated documentation capabilities which facilitate efficient patient interactions. The transactional structure is designed to simplify administrative tasks, allowing providers to enhance their focus on patient care. Specific pricing plans and detailed transaction structures are not disclosed; however, the general framework suggests that healthcare providers engage with Juvoly through direct subscriptions, securing access to the company's sophisticated tools for reducing administrative burdens.

This model supports a steady revenue stream from a growing number of healthcare organizations seeking innovative solutions to enhance operational efficiency and clinical outcomes. In January 2026, Juvoly B. V. will be acquired by Tandem Health AB, a move aimed at leveraging combined capabilities to drive economies of scale and support European expansion.

Future growth plans include the development of new products, although specific release dates are not mentioned. The acquisition will also facilitate Juvoly's entry into new markets across Europe.